Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

677
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
677
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

463
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
463
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

372
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
372
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

1.2K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Five year-results of chemoresistance testing in cancer patients].

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2012
Same author

Binding of proteins to ultra high molecular weight polyethylene wear particles as a possible mechanism of macrophage and lymphocyte activation.

Journal of biomedical materials research. Part A·2010
Same author

Chemopreventive compounds--view from the other side.

Chemico-biological interactions·2009
Same author

[The salvage of ischaemic limb by therapeutical angiogenesis].

Vnitrni lekarstvi·2009
Same author

Oxidation pattern of the anticancer drug ellipticine by hepatic microsomes - similarity between human and rat systems.

General physiology and biophysics·2007
Same author

[New beta0-thalassaemic insertion mutation (CD 7/8, +G) in a Slovak family, associated with the Mediterranean haplotype IX].

Vnitrni lekarstvi·2005

Related Experiment Video

Updated: Mar 27, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.5K

[Thrombophilia in pregnacy].

J Chudej, I Plameňová, J Hudeček

    Ceska Gynekologie
    |January 8, 2016
    PubMed
    Summary

    Anticoagulation can prevent and treat venous thrombosis in pregnant women. While beneficial for acquired thrombophilia, its use in inherited thrombophilia with miscarriage history is debated.

    Area of Science:

    • Obstetrics and Gynecology
    • Hematology
    • Thrombosis Research

    Background:

    • Thrombophilia poses risks during pregnancy, including venous thromboembolism.
    • Understanding thrombophilia in pregnancy is crucial for maternal and fetal health.

    Purpose of the Study:

    • To provide a comprehensive overview of current knowledge on thrombophilia in pregnant women.
    • To synthesize evidence regarding anticoagulation strategies for thrombophilia during pregnancy.

    Main Methods:

    • Literature review of available scientific sources.
    • Overview study design analyzing existing data.

    Main Results:

    • Anticoagulation demonstrates efficacy in prophylaxis and treatment of venous thrombosis in pregnancy.
    Keywords:
    complications.pregnacytrombophilia

    More Related Videos

    Ferric Chloride-induced Murine Thrombosis Models
    10:37

    Ferric Chloride-induced Murine Thrombosis Models

    Published on: September 5, 2016

    23.5K
    The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
    06:59

    The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

    Published on: February 27, 2026

    85

    Related Experiment Videos

    Last Updated: Mar 27, 2026

    Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
    13:08

    Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

    Published on: September 9, 2012

    19.5K
    Ferric Chloride-induced Murine Thrombosis Models
    10:37

    Ferric Chloride-induced Murine Thrombosis Models

    Published on: September 5, 2016

    23.5K
    The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
    06:59

    The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

    Published on: February 27, 2026

    85
  • Evidence supports anticoagulation for acquired thrombophilia during pregnancy.

    • Conclusions:

    • Anticoagulation is recommended for pregnant women with acquired thrombophilia.
    • The role of anticoagulation in inherited thrombophilia with a history of miscarriage requires further investigation.